Biotech Analyst Fadia holds a conference call with CEO Gano to discuss Ingrezza growth outlook and recent data readouts for NBI-1117568 and NBI-1065845 on November 6 at 1 pm hosted by Needham.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NBIX:
- NBIX Earnings this Week: How Will it Perform?
- AbbVie price target raised to $195 from $185 at BofA
- Neurocrine price target lowered to $114 from $128 at BMO Capital
- Neurocrine Biosciences Names Dr. Gano as President and CEO
- Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
